Cargando…
An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease
AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324354/ https://www.ncbi.nlm.nih.gov/pubmed/36852451 http://dx.doi.org/10.1111/cns.14141 |
_version_ | 1785069134258634752 |
---|---|
author | Hua, Ye Han, Wenjing Zhou, Linfeng Gao, Jing Zhao, Jifeng Song, Nanshan Hu, Bin Yao, Qingyu Liu, Yumin Xu, Deen Lu, Yunnan Fan, Yi |
author_facet | Hua, Ye Han, Wenjing Zhou, Linfeng Gao, Jing Zhao, Jifeng Song, Nanshan Hu, Bin Yao, Qingyu Liu, Yumin Xu, Deen Lu, Yunnan Fan, Yi |
author_sort | Hua, Ye |
collection | PubMed |
description | AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To access the alterations of NTN‐1 and DCC during the onset and progression of PD, we first established two subacute and one chronic PD model. Then, we investigated the relationship between the NTN‐1/DCC pathway and cell death in SH‐SY5Y cells. Finally, we conducted correlation studies between plasma NTN‐1 and parkinsonian symptoms in patients to understand how this pathway contributes to PD. RESULTS: We found that the imbalance of NTN‐1 and DCC was a common feature of nigral DA neuron injury in PD mouse models. We investigated that MPP+ inhibited NTN‐1 expression and increased DCC expression in a concentration‐ and time‐dependent manner. We further discovered a significant decrease in plasma NTN‐1 levels and a positive correlation with UPDRS scores in PD patients. CONCLUSION: Our findings confirmed the imbalance of NTN‐1/DCC signaling during nigral degeneration in experimental PD models and found for the first time a correlation of plasma NTN‐1 with PD symptoms in patients. |
format | Online Article Text |
id | pubmed-10324354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-103243542023-07-07 An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease Hua, Ye Han, Wenjing Zhou, Linfeng Gao, Jing Zhao, Jifeng Song, Nanshan Hu, Bin Yao, Qingyu Liu, Yumin Xu, Deen Lu, Yunnan Fan, Yi CNS Neurosci Ther Original Articles AIMS: Multiple guidance cues, such as netrin‐1 (NTN‐1)/deleted in colorectal carcinoma (DCC), control the guidance of axons and help establish functional neural circuits during development. However, the function of these guidance molecules during the neurodegenerative process is unclear. METHODS: To access the alterations of NTN‐1 and DCC during the onset and progression of PD, we first established two subacute and one chronic PD model. Then, we investigated the relationship between the NTN‐1/DCC pathway and cell death in SH‐SY5Y cells. Finally, we conducted correlation studies between plasma NTN‐1 and parkinsonian symptoms in patients to understand how this pathway contributes to PD. RESULTS: We found that the imbalance of NTN‐1 and DCC was a common feature of nigral DA neuron injury in PD mouse models. We investigated that MPP+ inhibited NTN‐1 expression and increased DCC expression in a concentration‐ and time‐dependent manner. We further discovered a significant decrease in plasma NTN‐1 levels and a positive correlation with UPDRS scores in PD patients. CONCLUSION: Our findings confirmed the imbalance of NTN‐1/DCC signaling during nigral degeneration in experimental PD models and found for the first time a correlation of plasma NTN‐1 with PD symptoms in patients. John Wiley and Sons Inc. 2023-02-27 /pmc/articles/PMC10324354/ /pubmed/36852451 http://dx.doi.org/10.1111/cns.14141 Text en © 2023 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Hua, Ye Han, Wenjing Zhou, Linfeng Gao, Jing Zhao, Jifeng Song, Nanshan Hu, Bin Yao, Qingyu Liu, Yumin Xu, Deen Lu, Yunnan Fan, Yi An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title | An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title_full | An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title_fullStr | An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title_full_unstemmed | An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title_short | An imbalance of netrin‐1 and DCC during nigral degeneration in experimental models and patients with Parkinson's disease |
title_sort | imbalance of netrin‐1 and dcc during nigral degeneration in experimental models and patients with parkinson's disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324354/ https://www.ncbi.nlm.nih.gov/pubmed/36852451 http://dx.doi.org/10.1111/cns.14141 |
work_keys_str_mv | AT huaye animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT hanwenjing animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT zhoulinfeng animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT gaojing animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT zhaojifeng animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT songnanshan animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT hubin animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT yaoqingyu animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT liuyumin animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT xudeen animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT luyunnan animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT fanyi animbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT huaye imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT hanwenjing imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT zhoulinfeng imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT gaojing imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT zhaojifeng imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT songnanshan imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT hubin imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT yaoqingyu imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT liuyumin imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT xudeen imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT luyunnan imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease AT fanyi imbalanceofnetrin1anddccduringnigraldegenerationinexperimentalmodelsandpatientswithparkinsonsdisease |